关于特布他林、布地奈德联合雾化吸入运用于儿童肺炎支原体肺炎的有效性分析

Analysis of Effectiveness of Terbutaline, Budesonide and Nebulization in the Child Mycoplasmal Pneumonia

目的分析特布他林、布地奈德联合雾化吸入用于儿童肺炎支原体肺炎的效果。方法随机选取2015年8月—2016年10月该院收治的肺炎支原体肺炎患儿60例,分为两组,对照组用常规治疗,研究组应用特布他林、布地奈德联合雾化吸入治疗,对比两组治疗疗效。结果研究组治疗后咳嗽消失时间(5.11±1.23)d、体温恢复时间(3.12±0.25)d、啰音消失时间(4.11±0.23)d、平均住院天数(7.11±0.28)d,对照组治疗后咳嗽消失时间(7.23±0.65)d、体温恢复时间(4.79±0.59)d、啰音消失时间(6.05±1.21)d、平均住院天数(9.97±1.26)d(P<0.05);且研究组治疗后临床总有效率96.67%,高于对照组的80.00%(P<0.05)。结论特布他林、布地奈德联合雾化吸入用于治疗儿童肺炎支原体肺炎的效果显著,值得推广。

Objective To analyze the effect of terbutaline, budesonide and nebulization in the child mycoplasmal pneumonia. Methods Random selection 60 cases of children with mycoplasmal pneumonia admitted and treated in our hospital from August 2015 to October 2016 were selected and divided into two groups, the control group were treated with routine method, while the research group were treated with terbutaline, budesonide and nebulization, and the treatment curative effect of the two groups was compared. Results The cough disappearance time, body temperature rehabilitation time, rale disappearance time and average length of stay after treatment were respectively（5.11±1.23）,（3.12±0.25）,（4.11±0.23）d and（7.11±0.28）d in the research group and（7.23±0.65）,（4.79±0.59）,（6.05±1.21）d and（9.97±1.26）d（P〈0.05）, and the total clinical effective rate after treatment in the research group was higher than that in the control group（96.67% vs 80.00%）（ P〈0.05）.Conclusion The effect of terbutaline, budesonide and nebulization in the child mycoplasmal pneumonia is obvious, which is worth promotion.